Target intelligence / Profile preview

Leucine rich repeat containing 40 pseudogene (None established; often referenced by the Ensembl identifier (ENSG00000270421) or as "LRRC40 pseudogene.")

Target
None established; often referenced by the Ensembl identifier (ENSG00000270421) or as "LRRC40 pseudogene."
Molecular classification
Pseudogene
01

Overview

The "leucine rich repeat containing 40 pseudogene" is a DNA segment resembling the functional *leucine rich repeat containing 40* (LRRC40) gene, but with mutations such as frameshifts or premature stop codons that prevent production of a functional protein[4][6]. Pseudogenes arise either by gene duplication/retrotransposition or by disabling mutations in a previously functional gene[2][6]. In humans, pseudogenes are prevalent and may complicate genome annotation and genetic analysis, but most do not have direct functional or therapeutic relevance[6]. For context, the **LRRC40 gene** (distinct from the pseudogene) encodes a protein believed to participate in protein-protein interactions, contains leucine-rich repeats, and is conserved across many species[1]. However, the pseudogene variant is nonfunctional and does not produce protein; any biological effects would be through RNA interactions, which are not well-characterized for this locus[2][6]. If you are seeking information about a *therapeutic target*, you should refer to the functional **LRRC40 protein** and not the pseudogene. The presence of "pseudogene" in the canonical designation is a clear indication of nonfunctionality in classical molecular biology and drug targeting contexts[4][6].

Other names
LRRC40 pseudogeneleucine-rich repeat containing 40 pseudogeneENSG00000270421
02

Mechanism of action

Not applicable. No mechanistically-targeted drugs or interventions exist for this pseudogene.

03

Biological functions

Most pseudogenes do not perform classical biological functions due to a lack of protein expression. Some may have low-level transcription or regulatory roles in rare cases, but this is the exception and not the rule.
04

Disease associations

Generally, pseudogenes are not direct disease drivers. Some specific pseudogenes have been linked to regulatory effects in cancer and other diseases, but no clear evidence exists for this particular pseudogene.
05

Safety considerations

None specific. The main challenge is that pseudogene sequence similarity can confound molecular genetic studies, leading to PCR bias or incorrect annotation as functional genes.
06

Interacting drugs

None. Pseudogenes are not known to interact with drugs because they do not encode active proteins or functional gene products.
07

Biomarkers

None established. Pseudogenes are occasionally used as markers in molecular assays (e.g., to control for amplification bias) but not as clinical biomarkers for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Leucine rich repeat containing 40 pseudogene (None established; often referenced by the Ensembl identifier (ENSG00000270421) or as "LRRC40 pseudogene.").

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine rich repeat containing 40 pseudogene (None established; often referenced by the Ensembl identifier (ENSG00000270421) or as "LRRC40 pseudogene.").

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call